Delivery Order SPE2DB22D1106-SPE2DB25FEHA8
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,180.41, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75 ml. The contract is a firm fixed-price delivery order with a completion date of December 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,540.65, is for the delivery of the drug Wegovy 1 mg/0.5 ml pen in 0.5 ml quantities. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 11, 2025. This award is not associated with a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,376.21, is for the delivery of the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,163.99, is for the delivery of Wegovy 0.25 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a final completion date of February 10, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.99, is a delivery order for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.25, is for the delivery of Wegovy 1 mg/0.5 ml pens. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,326.97 and is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed price contract with an ultimate completion date of March 12, 2025. AmerisourceBergen is the prime contractor, and the contract is not designated as a set-aside. The contract is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,251.41, is a delivery order for the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with a completion date of February 13, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,764.39 firm fixed-price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pen medication. The contract has an ultimate completion date of May 9, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen in 0.5 ml quantities. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 31, 2024. The contract does not have a set-aside designation, indicating open competition. In addition to this...